| Dr Brendan Jeffrey Ringhouse, MD | |
|
9650 Gross Point Rd Ste 3900, Skokie, IL 60076-5085 | |
| (847) 570-1700 | |
| (224) 251-5470 |
| Full Name | Dr Brendan Jeffrey Ringhouse |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 9650 Gross Point Rd Ste 3900, Skokie, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285920124 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 036166300 (Illinois) | Primary |
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
Federal financing for a beneficial health insurance program for low-income children, known as the Children's Health Insurance Program or CHIP, will run out next year unless Congress agrees to extend it. Bills are pending in both the House and the Senate to extend financing for four years, to 2019. Congress should approve the extension in the lame-duck session after the midterm elections so that families and state officials will know what the future holds. The program needs to be maintained amid uncertainty as to whether other good coverage will be available for these children (9/21).
A Singapore team led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) discovered a genetic link to better predict treatment response for relapsed/refractory patients with natural- killer T-cell lymphoma (NKTCL), a highly aggressive form of blood cancer.
Repligen Corporation announced today that the United States Patent and Trademark Office has granted a Notice of Allowance of a patent covering the use of uridine in the treatment of patients with bipolar disorder. The patent, which upon issue will remain in force until 2025 prior to any patent term extensions, covers the use of an effective dose of a uridine composition to improve one or more of the symptoms of bipolar disorder including depression, mania, mixed episodes, hypomania and anxiety.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brendan Jeffrey Ringhouse, MD 9650 Gross Point Rd Ste 3900, Skokie, IL 60076-5085 Ph: (847) 570-1700 | Dr Brendan Jeffrey Ringhouse, MD 9650 Gross Point Rd Ste 3900, Skokie, IL 60076-5085 Ph: (847) 570-1700 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
Federal financing for a beneficial health insurance program for low-income children, known as the Children's Health Insurance Program or CHIP, will run out next year unless Congress agrees to extend it. Bills are pending in both the House and the Senate to extend financing for four years, to 2019. Congress should approve the extension in the lame-duck session after the midterm elections so that families and state officials will know what the future holds. The program needs to be maintained amid uncertainty as to whether other good coverage will be available for these children (9/21).
A Singapore team led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) discovered a genetic link to better predict treatment response for relapsed/refractory patients with natural- killer T-cell lymphoma (NKTCL), a highly aggressive form of blood cancer.
Repligen Corporation announced today that the United States Patent and Trademark Office has granted a Notice of Allowance of a patent covering the use of uridine in the treatment of patients with bipolar disorder. The patent, which upon issue will remain in force until 2025 prior to any patent term extensions, covers the use of an effective dose of a uridine composition to improve one or more of the symptoms of bipolar disorder including depression, mania, mixed episodes, hypomania and anxiety.
› Verified 3 days ago
Mr. Peter Jae Ho Hwang, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd Ste 3900, Skokie, IL 60076 Phone: 847-570-1700 Fax: 847-982-1098 | |
Dr. Constantine T Frantzides, MD, PHD, FACS Surgery Medicare: Not Enrolled in Medicare Practice Location: 4905 Old Orchard Shopping Ctr, Suite 409, Skokie, IL 60077 Phone: 847-676-2200 Fax: 847-676-1813 | |
Nancy Schindler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9977 Woods Dr, 3rd Floor, Skokie, IL 60077 Phone: 847-663-8050 Fax: 847-663-8054 | |
Minh-tri Nhat Pham, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd Ste 3900, Skokie, IL 60076 Phone: 847-570-1700 Fax: 847-982-1098 | |
Dr. Bryan Phillip Hendren, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd Ste 3900, Skokie, IL 60076 Phone: 847-570-1700 Fax: 847-982-1098 | |
Katlynn Paul, PA-C Surgery Medicare: Not Enrolled in Medicare Practice Location: 9650 Gross Point Rd Ste 3900, Skokie, IL 60076 Phone: 847-570-1700 |